Interleukin 18 and hepatocyte growth factor in fulminant hepatic failure of adult onset Still's disease

Journal of Rheumatology

Volumn 30, Issue 5, 2003, Pages 1093-1096

  Ogata, Atsushi ^a   Kitano, Masayasu ^a   Yamanaka, Jyunichi ^a   Yamasaki, Tomoko ^a   Hashimoto, Naoaki ^a   Iwasaki, Tsuyoshi ^a   Hamano, Teruaki ^a   Fujimoto, Jiro ^a   Kakishita, Eizo ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

Adult onset Still's disease; Fulminant hepatic failure; Hepatocyte growth factor; Interleukin 18; Liver transplant

Indexed keywords

C REACTIVE PROTEIN; CYCLOSPORIN A; FERRITIN; INTERLEUKIN 18; METHOTREXATE; PREDNISOLONE; SCATTER FACTOR; TACROLIMUS;

ADULT; ADULT ONSET STILL DISEASE; AMENORRHEA; ARTICLE; CASE REPORT; FEMALE; FEVER; HUMAN; LIVER DYSFUNCTION; LIVER FAILURE; LIVER NECROSIS; LIVER TRANSPLANTATION; POLYARTHRITIS; PRIORITY JOURNAL; RASH; RHEUMATIC DISEASE;

ADULT; FEMALE; HEPATOCYTE GROWTH FACTOR; HUMANS; INTERLEUKIN-18; LIVER FAILURE; LIVER TRANSPLANTATION; STILL'S DISEASE, ADULT-ONSET;

EID: 0038071923     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Bywaters EG. Still's disease in the adult. Ann Rheum Dis 1971;30:121-33.
2. Yamaguchi M, Ohta A, Tsunematsu T, et al. Preliminary criteria for classification of adult Still's disease. J Rheumatol 1992;19:424-30.
3. Gonzalez-Hernandez T, Martin-Mola E, Fernandez-Zamorano A, Balsa-Criado A, de Miguel-Mendieta E. Serum ferritin can be useful for diagnosis in adult onset Still's disease. J Rheumatol 1989;16:412-3.
4. Kawashima M, Yamamura M, Taniai M, et al. Levels of interleukin-18 and its binding inhibitors in the blood circulation of patients with adult-onset Still's disease. Arthritis Rheum 2001;44:550-60.
5. Dino O, Provenzano G, Giannuoli G, Sciarrino E, Pouyet M, Pagliaro L. Fulminant hepatic failure in adult onset Still's disease. J Rheumatol 1996;23:784-5.
6. McFarlane M, Harth M, Wall WJ. Liver transplant in adult Still's disease. J Rheumatol 1997;24:2038-41.
7. Ohta A, Yamaguchi M, Kaneoka H, Nagayoshi T, Hiida M. Adult Still's disease: review of 228 cases from the literature. J Rheumatol 1987;14:1139-46.
8. Mondragon RS, Karani JB, Heaton ND, et al. The use of percutaneous transluminal angioplasty in hepatic artery stenosis after transplantation. Transplantation 1994;57:228-31.
9. Jung JH, Jun JB, Yoo DH, et al, High toxicity of sulfasalazine in adult-onset Still's disease. Clin Exp Rheumatol 2000;18:245-8.
10. Crowley J, Situnayake RD. Sulphasalazine induced hepatitis in adult Still's disease. Ann Rheum Dis 1992;51:1264-5.
11. Maclachlan D, Tyndall A. Acute hepatitis in adult Still's disease apparently resulting from oral iron substitution: a case report. Clin Rheumatol 2000;19:222-5.
12. Janssen HL, van Laar JM, van Hoek B, den Ottolander GJ, van Krieken JH, Breedveld FC. Severe hepatitis and pure red cell aplasia in adult Still's disease: good response to immunosuppressive therapy. Dig Dis Sci 1999;44:1639-42.
13. Castanet J, Lacour JP, Fuzibet JG, Perrin C, Rodot S, Ortonne JP. Adult Still's disease associated with hepatitis C virus infection. J Am Acad Dermatol 1994;31:807-8.
14. Longo G, Luppi M, Bertesi M, Ferrara L, Torelli G, Emilia G. Still's disease, severe thrombocytopenia, and acute hepatitis associated with acute parvovirus B19 infection. Clin Infect Dis 1998;26:994-5.
15. Sridharan S, Mossad S, Hoffman G. Hepatitis A infection mimicking adult onset Still's disease. J Rheumatol 2000;27:1792-5.
16. Nishida T, Suzuki K, Kuwada N, Nakamura Y, Motoyoshi K, Kamakura K. Hemophagocytic syndrome and adult Still's disease associated with meningoencephalitis and unconsciousness. Intern Med 2001;40:1037-40.
17. Takami A, Nakao S, Miyamori H, et al. Adult-onset Still's disease with submassive hepatic necrosis. Intern Med 1995;34:89-91.
18. Yumoto E, Higashi T, Nouso K, T et al. Serum gamma-interferon-inducing factor (IL-18) and IL-10 levels in patients with acute hepatitis and fulminant hepatic failure. J Gastroenterol Hepatol 2002;17:285-94.
19. Tsutsui H, Matsui K, Okamura H, Nakanishi K. Pathophysiological roles of interleukin-18 in inflammatory liver diseases. Immunol Rev 2000;174:192-209,
20. Sakao Y, Takeda K, Tsutsui H, et al. IL-18-deficient mice are resistant to endotoxin-induced liver injury but highly susceptible to endotoxin shock. Int Immunol 1999;11:471-80.